Actualités
Tous les liens de cette page renvoient vers des résumés d’articles (abstracts). L’ensemble des versions intégrales sont disponibles au Centre de Psychiatrie Interventionnelle. Vous pouvez également les consulter ou les acheter sur le site de l’éditeur.
PSYCHIATRIE INTERVENTIONNELLE EN SUISSE
Société suisse de psychiatrie interventionnelle (SSPI)
Autres spécialistes en Suisse
- Genève : Dr Fady Rachid (TMS)
- Zürich : Dr Michael Fischer (TMS et autres techniques)
INFORMATIONS GÉNÉRALES SUR LA TMS
EFFICACITÉ ET SÉCURITÉ DE LA TMS
EFFICACITÉ DE LA TMS DANS LA DÉPRESSION
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. (Brain Stimulation)
The expanding evidence base for rTMS treatment of depression. (Current Opinion in Psychiatry)
Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. (Journal of Clinical Psychiatry)
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. (Biological Psychiatry)
Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial. (Psychiatry Research)
Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls (World Journal of Psychiatry)
EFFICACITÉ DE LA TMS DANS D’AUTRES INDICATIONS
Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study (European Neuropsychopharmacology)
Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature. (Archives of Physical Medicine and Rehabilitation)
Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. (Pain)
Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder. (Brain Stimulation)
An Update of the Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients with Obsessive Compulsive Disorder. (Journal of Neuropsychiatry)
Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial. (JAMA Otolaryngoloy – head & Neck Surgery)
Repetitive Transcranial Magnetic Stimulation for Phantom Limb Pain in Land Mine Victims: A Double-Blinded, Randomized, Sham-Controlled Trial. (Journal of Pain)
Brain Stimulation in Alzheimer’s Disease. (Frontiers in Psychiatry)
Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease. (Neurophysiologie clinique)
Neuromodulation for the treatment of eating disorders and obesity. (Therapeutic Advances in Psychopharmacology)
EFFICACITÉ DE L’ECT DANS LA DÉPRESSION
Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. (Journal of Clinical Psychopharmacology)
Relapse Following Successful Electroconvulsive Therapy For Major Depression: A Meta- Analysis. (Neuropsychopharmacology)
Maintenance electroconvulsive therapy up to 12 years. (Journal of Affective Disorders)
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. (The British Journal of Psychiatry)
Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression. (Current psychiatry reports)
Improvements in Health-Related Quality of Life With Electroconvulsive Therapy – A Meta-analysis. (The Journal of ECT)
ECT ET TROUBLE BIPOLAIRE
Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive Therapy Versus Algorithm-Based Pharmacological Treatment. (American Journal of Psychiatry)
Electroconvulsive therapy in bipolar depression – effectiveness and prognostic factors Treatment. (Acta Psychiatrica Scandinavica)
What happens to the course of bipolar disorder after electroconvulsive therapy? (Journal of Affective Disorders)
ECT ET SCHIZOPHRÉNIE
ECT in schizophrenia: a review of the evidence. (Acta Psychiatrica Scandinavica)
Electroconvulsive Therapy and Schizophrenia – A Systematic Review (Molecular Neuropsychiatry)
Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness. (Neuropsychobiology)
Electroconvulsive therapy in ultra-resistant schizophrenia – A case series. (Asian Journal of Psychiatry)
Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A retrospective Cohort Study (Journal of ECT)
AUDIO & VIDEO
TMS en psychiatrie – AP-HM mag flash, Assistance Publique-Hôpitaux de Marseille
TMS Brain Stimulation Can Help Combat Depression, Beth Israel Deaconess Medical Center, Boston
Ketamine for Treatment-Refractory Depression – Video Interview with James Murrough, MD
Des électrochocs contre la dépression. Emission 36,9° du 10.05.2017, RTS1
L’électricité pour lutter contre la dépression. Emission CQFD du 30.08.2018, RTS La 1ère
Dépression, de l’ombre à la lumière. Emission Temps Présent du 06.12.2018, RTS1
KÉTAMINE ET DÉPRESSION
A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. (American Journal of Psychiatry)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. (journal of affective disorders)
Kétamine comme option thérapeutique (Swiss Medical Forum)
How club drug ketamine fights depression (Nature)
Rave drug holds promise for treating depression fast (Nature)
ketamine: stimulating antidepressant treatment? (British Journal of Psychiatry)
Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice (Depression and Anxiety)
Ketamine for treatment-resistant depression: recent developments and clinical applications. (British Medical Journal)
Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment. (American Journal of Psychiatry)
Ketamine: a potential rapid-acting antisuicidal agent? (Depression and Anxiety)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites. (Nature)
A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. (Journal of Affective Disorders)
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. (Journal of Affective Disorders)
Administration of ketamine for unipolar and bipolar depression. (International Journal of Psychiatry in Clinical Practice)
What is the mechanism of Ketamine’s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. (Journal of clinical pharmacy and therapeutics)
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity. (Journal of Psychopharmacology)
KÉTAMINE DANS D’AUTRES INDICATIONS
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders – a review of the literature. (CNS Spectrums)
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder – proof-of-concept. (Neuropsychopharmacology)
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient with Treatment-Resistant Obsessive-Compulsive Disorder – A Case Report. (Journal of Clinical Psychiatry)
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. (Journal of Psychopharmacology)
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. (JAMA Psychiatry)
ESKÉTAMINE INTRANASALE ET DEPRESSION
ECT : SECURITÉ, MÉCANISMES, EFFETS SECONDAIRES
Neuropathological evaluation of an 84-year-old man after 422 ECT treatments. (Journal of ECT)
Electroconvulsive therapy increases temporal gray matter volume and cortical thickness. (European Neuropsychopharmacology)
Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis. (Biological Psychiatry)
Evaluation of cumulative cognitive deficits from electroconvulsive therapy. (British Journal of Psychiatry).
An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System. (Journal of ECT)
Neurotransmitters and Electroconvulsive Therapy. (Journal of ECT)
Hippocampal Neurogenesis and Antidepressive Therapy: Shocking Relations. (Neural Plasticity)
Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study. (Journal of Psychiatry & Neuroscience)
Effect of electroconvulsive therapy on gray matter volume in major depressive disorder. (Journal of Affective Disorders)
Mechanisms of Antidepressant Response to Electroconvulsive Therapy Studied With Perfusion Magnetic Resonance Imaging. (Biological Psychiatry)
Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression. (Brain Stimulation)
Long-Term Cognitive and Psychological Functioning in Post–Electroconvulsive Therapy Patients. (Journal of ECT)
Electroconvulsive therapy and risk of dementia in patients with affective disorders – a cohort study. (Lancet Psychiatry)